← Back to all trials
Recruiting
NCT06328127
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
Conditions: Hematopoietic Stem Cell Transplant
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 400
Sponsor: Brigham and Women's Hospital
Location: Moffitt Cancer Center Tampa Florida
Summary
This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Eligibility Criteria
Inclusion Criteria:
* Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
* Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
* Access to a basic telephone
Exclusion Criteria:
* Patients who underwent allogeneic HSCT for benign hematologic conditions
* Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures
Source: ClinicalTrials.gov (NCT06328127). StuddyBuddy aggregates publicly available trial information.